Cohen Fred E is a director of UroGen Pharma Ltd.
Person profile
Roles
Address
Fort Worth, Texas
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Intellia Therapeutics, Inc.
14 Jun 24
4
Progyny, Inc.
28 May 24
4
Kyverna Therapeutics, Inc.
14 Feb 24
3
Kyverna Therapeutics, Inc.
7 Feb 24
4
UroGen Pharma Ltd.
8 Sep 23
4
UroGen Pharma Ltd.
28 Jul 23
4
CareDx, Inc.
21 Jun 23
4
Intellia Therapeutics, Inc.
16 Jun 23
4
Progyny, Inc.
26 May 23
4
CareDx, Inc.
9 Jan 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Jun 24 | NTLA Intellia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 7,737 | 0.00 | 49,453 |
12 Jun 24 | NTLA Intellia Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 25.85 | 11,515 | 297.66 k | 11,515 |
23 May 24 | PGNY Progyny | Common Stock | Grant | Acquire A | No | No | 0 | 6,176 | 0.00 | 22,693 |
23 May 24 | PGNY Progyny | Stock Option Common Stock | Grant | Acquire A | No | No | 27.15 | 25,070 | 680.65 k | 25,070 |
12 Feb 24 | KYTX Kyverna Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 4,523,924 | 0.00 | 4,523,924 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series B Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 7,356,162 | 0.00 | 0 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series A-2 Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 8,830,901 | 0.00 | 0 |
12 Feb 24 | KYTX Kyverna Therapeutics | Series A-1 Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 4,401,771 | 0.00 | 0 |
7 Sep 23 | URGN UroGen Pharma | Stock Option (right ot buy) Ordinary Shares | Grant | Acquire A | No | No | 16.85 | 10,000 | 168.50 k | 10,000 |